Drug Profile
Staphylococcus aureus vaccine - Jiangsu Province Centers for Disease Control and Prevention
Latest Information Update: 28 Jun 2022
Price :
$50
*
At a glance
- Originator Jiangsu Provincial Center for Disease Control and Prevention
- Developer Chengdu Olymvax Biopharmaceuticals; Jiangsu Provincial Center for Disease Control and Prevention; Third Military Medical University
- Class Bacterial vaccines; Conjugate vaccines; Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Staphylococcal infections
Most Recent Events
- 28 Jun 2022 No recent reports of development identified for phase-I development in Staphylococcal-infections(Prevention) in China (Parenteral)
- 16 May 2020 Jiangsu Province Centers for Disease Control and Prevention completes a phase-I trial in Staphylococcal infections (Prevention) in China (Parenteral) (NCT03966040)
- 16 May 2019 Phase-I clinical trials in Staphylococcal infections (Prevention) in China (Parenteral) (NCT03966040)